Quince Therapeutics Inc (QNCX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -44,521 | -31,079 | -15,030 | -56,828 | -44,370 |
| Depreciation Amortization | -723 | -523 | -323 | 14,968 | 15,442 |
| Accounts payable and accrued liabilities | 214 | -1,417 | 22 | 927 | -424 |
| Other Working Capital | 373 | 179 | 2,051 | -484 | -2,379 |
| Other Operating Activity | 13,713 | 11,824 | 3,679 | 9,513 | 7,379 |
| Operating Cash Flow | $-30,944 | $-21,016 | $-9,601 | $-31,904 | $-24,352 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 31,000 | N/A | N/A | N/A |
| PPE Investments | -348 | -274 | -148 | -257 | -124 |
| Purchase Of Investment | -29,496 | -13,789 | -1,954 | -89,562 | -89,562 |
| Sale Of Investment | 45,000 | N/A | 13,000 | 111,727 | 100,727 |
| Investing Cash Flow | $15,156 | $16,937 | $10,898 | $21,908 | $11,041 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 15,875 | 14,499 | 87 | 225 | 225 |
| Other Financing Activity | 0 | 0 | 0 | -5,000 | -5,000 |
| Financing Cash Flow | $15,875 | $14,499 | $87 | $-4,775 | $-4,775 |
| Exchange Rate Effect | 153 | 194 | 175 | 231 | 9 |
| Beginning Cash Position | 6,212 | 6,212 | 6,212 | 20,752 | 20,752 |
| End Cash Position | 6,452 | 16,826 | 7,771 | 6,212 | 2,675 |
| Net Cash Flow | $240 | $10,614 | $1,559 | $-14,540 | $-18,077 |
| Free Cash Flow | |||||
| Operating Cash Flow | -30,944 | -21,016 | -9,601 | -31,904 | -24,352 |
| Capital Expenditure | -348 | -274 | -148 | -257 | -124 |
| Free Cash Flow | -31,292 | -21,290 | -9,749 | -32,161 | -24,476 |